2015 – 2025 GLOBAL GLYCOBIOLOGY MARKET FORECAST & OPPORTUNITIES
www.techsciresearch.com MARKET INTELLIGENCE . CONSULTING
Scope of Report Product of Interest (POI): Glycobiology
Global glycobiology market is expected to grow at a formidable rate during the forecast period. The global glycobiology market is driven by the growing prevalence of chronic diseases such as cancer, diabetics, renal diseases, among others, which has increased the demand for personalized medicines. This in turn has increased the drug discovery process around the globe, which is anticipated to positively impact growth of market during the forecast period. Also, increasing grants by different governments especially in the developing nations for R&D activities is further expected to bolster the growth of market over the next few years. Market Segmentation TYPE OF KIT
TYPE OF ENZYME •
Glycosidases & Neuramidases
•
Glycosyltransferases & Sialytransferases
•
Carbohydrate Kinases
•
Carbohydrate Sulfotransferases
•
Protein Sulfotransferases
•
Others
•
Glycan Releasing Kit
•
Glycan Labelling Kit
•
Glycan Purification Kit
•
Others
END USER APPLICATION
•
Drug Discovery
•
Disease Diagnostics
•
Virology
•
Cell Biology
•
Oncology
•
Others
Year Range REGION •
North America
•
Europe
•
Middle East & Africa
•
Asia-Pacific
•
South America
•
Research Institutes
•
Diagnostic Centers
•
Hospitals
•
Clinical Laboratories
•
Pharmaceutical & Biotechnology Companies
•
Others
Review Period
2015 – 2018 Base Year
2019 Estimated Year
2020 Forecast Period
2021 – 2025
2
Table of Contents S. No.
Contents
1.
Product Overview
2.
Research Methodology
3.
Impact of COVID-19 on Global Glycobiology Market
4.
Executive Summary
5.
Voice of Customer
6.
Global Glycobiology Market Outlook 6.1.
Market Size & Forecast 6.1.1.
6.2.
6.3.
Page No.
By Value
Market Share & Forecast
6.2.1.
By Type of Enzyme (Glycosidases & Neuramidases, Glycosyltransferases & Sialytransferases, Carbohydrate Kinases, Carbohydrate Sulfotransferases, Protein Sulfotransferases, Others)
6.2.2.
By Type of Kit (Glycan Releasing Kit, Glycan Labelling Kit, Glycan Purification Kit, Others)
6.2.3.
By Application (Drug Discovery, Disease Diagnostics, Virology, Cell Biology, Oncology, Others)
6.2.4.
By End User (Research Institutes, Diagnostic Centers, Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Others)
6.2.5.
By Company (2019)
6.2.6.
By Region (Asia-Pacific, Europe, North America, South America and Middle East & Africa)
Product Market Map
3
Table of Contents S. No. 7.
Contents
Page No.
Asia-Pacific Glycobiology Market Outlook 7.1.
Market Size & Forecast 7.1.1.
7.2.
7.3.
By Value
Market Share & Forecast 7.2.1.
By Type of Enzyme
7.2.2.
By Type of Kit
7.2.3.
By Application
7.2.4.
By End User
7.2.5.
By Country (China, India, Australia, Japan, South Korea)
Asia-Pacific: Country Analysis 7.3.1.
China Glycobiology Market Outlook 7.3.1.1.
Market Size & Forecast 7.3.1.1.1.
7.3.1.2.
By Value
Market Share & Forecast 7.3.1.2.1.
By Type of Enzyme
7.3.1.2.2.
By Type of Kit
7.3.1.2.3.
By Application
7.3.1.2.4.
By End User
4
Table of Contents S. No.
Contents
7.3.2.
India Glycobiology Market Outlook 7.3.2.1.
Market Size & Forecast 7.3.2.1.1.
7.3.2.2.
7.3.3.
By Value
Market Share & Forecast 7.3.2.2.1.
By Type of Enzyme
7.3.2.2.2.
By Type of Kit
7.3.2.2.3.
By Application
7.3.2.2.4.
By End User
Australia Glycobiology Market Outlook 7.3.3.1.
Market Size & Forecast
7.3.3.1.1. 7.3.3.2.
7.3.4.
Page No.
By Value
Market Share & Forecast 7.3.3.2.1.
By Type of Enzyme
7.3.3.2.2.
By Type of Kit
7.3.3.2.3.
By Application
7.3.3.2.4.
By End User
Japan Glycobiology Market Outlook
5
Table of Contents S. No.
Contents 7.3.4.1.
Market Size & Forecast 7.3.4.1.1.
7.3.4.2.
7.3.5.
By Value
Market Share & Forecast 7.3.4.2.1.
By Type of Enzyme
7.3.4.2.2.
By Type of Kit
7.3.4.2.3.
By Application
7.3.4.2.4.
By End User
South Korea Glycobiology Market Outlook 7.3.5.1.
Market Size & Forecast 7.3.5.1.1.
7.3.5.2.
8.
Page No.
By Value
Market Share & Forecast 7.3.5.2.1.
By Type of Enzyme
7.3.5.2.2.
By Type of Kit
7.3.5.2.3.
By Application
7.3.5.2.4.
By End User
Europe Glycobiology Market Outlook
6
Table of Contents S. No.
Contents 8.1.
Market Size & Forecast 8.1.1.
8.2.
8.3.
Page No.
By Value
Market Share & Forecast 8.2.1.
By Type of Enzyme
8.2.2.
By Type of Kit
8.2.3.
By Application
8.2.4.
By End User
8.2.5.
By Country (France, Germany, United Kingdom, Italy, Spain)
Europe: Country Analysis 8.3.1.
France Glycobiology Market Outlook 8.3.1.1.
Market Size & Forecast 8.3.1.1.1.
8.3.1.2.
By Value
Market Share & Forecast 8.3.1.2.1.
By Type of Enzyme
8.3.1.2.2.
By Type of Kit
8.3.1.2.3.
By Application
8.3.1.2.4.
By End User
7
Table of Contents S. No.
Contents 8.3.2.
Germany Glycobiology Market Outlook 8.3.2.1.
Market Size & Forecast 8.3.2.1.1.
8.3.2.2.
8.3.3.
By Value
Market Share & Forecast 8.3.2.2.1.
By Type of Enzyme
8.3.2.2.2.
By Type of Kit
8.3.2.2.3.
By Application
8.3.2.2.4.
By End User
United Kingdom Glycobiology Market Outlook
8.3.3.1.
Market Size & Forecast 8.3.3.1.1.
8.3.3.2.
8.3.4.
Page No.
By Value
Market Share & Forecast 8.3.3.2.1.
By Type of Enzyme
8.3.3.2.2.
By Type of Kit
8.3.3.2.3.
By Application
8.3.3.2.4.
By End User
Italy Glycobiology Market Outlook
8
Table of Contents S. No.
Contents 8.3.4.1.
Market Size & Forecast 8.3.4.1.1.
8.3.4.2.
8.3.5.
By Value
Market Share & Forecast 8.3.4.2.1.
By Type of Enzyme
8.3.4.2.2.
By Type of Kit
8.3.4.2.3.
By Application
8.3.4.2.4.
By End User
Spain Glycobiology Market Outlook 8.3.5.1.
Market Size & Forecast
8.3.5.1.1. 8.3.5.2.
9.
Page No.
By Value
Market Share & Forecast 8.3.5.2.1.
By Type of Enzyme
8.3.5.2.2.
By Type of Kit
8.3.5.2.3.
By Application
8.3.5.2.4.
By End User
North America Glycobiology Market Outlook 9.1.
Market Size & Forecast
9
Table of Contents S. No.
Contents 9.1.1. 9.2.
9.3.
Page No.
By Value
Market Share & Forecast 9.2.1.
By Type of Enzyme
9.2.2.
By Type of Kit
9.2.3.
By Application
9.2.4.
By End User
9.2.5.
By Country (United States, Canada, Mexico)
North America: Country Analysis
9.3.1.
United States Glycobiology Market Outlook
9.3.1.1.
Market Size & Forecast 9.3.1.1.1.
9.3.1.2.
9.3.2.
By Value
Market Share & Forecast
9.3.1.2.1.
By Type of Enzyme
9.3.1.2.2.
By Type of Kit
9.3.1.2.3.
By Application
9.3.1.2.4.
By End User
Canada Glycobiology Market Outlook 9.3.2.1.
Market Size & Forecast
10
Table of Contents S. No.
Contents 9.3.2.1.1.
9.3.2.2.
9.3.3.
By Value
Market Share & Forecast 9.3.2.2.1.
By Type of Enzyme
9.3.2.2.2.
By Type of Kit
9.3.2.2.3.
By Application
9.3.2.2.4.
By End User
Mexico Glycobiology Market Outlook 9.3.3.1.
Market Size & Forecast 9.3.3.1.1.
9.3.3.2.
10.
Page No.
By Value
Market Share & Forecast 9.3.3.2.1.
By Type of Enzyme
9.3.3.2.2.
By Type of Kit
9.3.3.2.3.
By Application
9.3.3.2.4.
By End User
South America Glycobiology Market Outlook 10.1.
Market Size & Forecast 10.1.1.
10.2.
By Value
Market Share & Forecast 10.2.1.
By Type of Enzyme
11
Table of Contents S. No.
Contents
10.3.
10.2.2.
By Type of Kit
10.2.3.
By Application
10.2.4.
By End User
10.2.5.
By Country (Brazil, Argentina, Colombia)
Page No.
South America: Country Analysis
10.3.1.
Brazil Glycobiology Market Outlook 10.3.1.1.
Market Size & Forecast 10.3.1.1.1
10.3.1.2.
10.3.2.
By Value
Market Share & Forecast 10.3.1.2.1.
By Type of Enzyme
10.3.1.2.2.
By Type of Kit
10.3.1.2.3.
By Application
10.3.1.2.4.
By End User
Argentina Glycobiology Market Outlook 10.3.2.1.
Market Size & Forecast 10.3.2.1.1
10.3.2.2.
By Value
Market Share & Forecast 10.3.2.2.1.
By Type of Enzyme
10.3.2.2.2.
By Type of Kit
12
Table of Contents S. No.
Contents
10.3.3.
10.3.2.2.3.
By Application
10.3.2.2.4.
By End User
Colombia Glycobiology Market Outlook 10.3.3.1.
Market Size & Forecast 10.3.3.1.1
10.3.3.2.
11.
Page No.
By Value
Market Share & Forecast 10.3.3.2.1.
By Type of Enzyme
10.3.2.2.2.
By Type of Kit
10.3.2.2.3.
By Application
10.3.2.2.4.
By End User
Middle East & Africa Glycobiology Market Outlook 11.1.
Market Size & Forecast 11.1.1.
11.2.
By Value
Market Share & Forecast 11.2.1.
By Type of Enzyme
11.2.2.
By Type of Kit
11.2.3.
By Application
11.2.4.
By End User
13
Table of Contents S. No.
Contents 11.2.5. 11.3.
Page No.
By Country (South Africa, Saudi Arabia, UAE)
Middle East & Africa : Country Analysis 11.3.1.
South Africa Glycobiology Market Outlook 11.3.1.1.
Market Size & Forecast 11.3.1.1.1.
11.3.1.2.
11.3.2.
Market Share & Forecast 11.3.1.2.1.
By Type of Enzyme
11.3.1.2.2.
By Type of Kit
11.3.1.2.3.
By Application
11.3.1.2.4.
By End User
Saudi Arabia Glycobiology Market Outlook
11.3.2.1.
Market Size & Forecast 11.3.2.1.1.
11.3.2.2.
11.3.3.
By Value
By Value
Market Share & Forecast 11.3.2.2.1.
By Type of Enzyme
11.3.2.2.2.
By Type of Kit
11.3.2.2.3.
By Application
11.3.2.2.4.
By End User
UAE Glycobiology Market Outlook 11.3.3.1.
Market Size & Forecast
14
Table of Contents S. No.
Contents 11.3.3.1.1. 11.3.3.2.
11.3.4.
By Value
Market Share & Forecast 11.3.3.2.1.
By Type of Enzyme
11.3.3.2.2.
By Type of Kit
11.3.3.2.3.
By Application
11.3.3.2.4.
By End User
Kuwait Glycobiology Market Outlook 11.3.4.1.
Market Size & Forecast 11.3.4.1.1.
11.3.4.2.
12.
Page No.
By Value
Market Share & Forecast
11.3.4.2.1.
By Type of Enzyme
11.3.4.2.2.
By Type of Kit
11.3.4.2.3.
By Application
11.3.4.2.4.
By End User
Market Dynamics 12.1.
Drivers
12.2.
Challenges
13.
Market Trends & Developments
14.
Competitive Landscape 14.1.
Competition Outlook
15
Table of Contents S. No.
Contents 14.2.
Page No.
Company Profiles
15.
Strategic Recommendations
16.
About Us & Disclaimer
16
RESEARCH METHODOLOGY
Research Methodology
Market Profiling
In-depth secondary research was conducted to determine top players in the global glycobiology market, overall market size and segmental market size.
Formulating Questionnaire
In order to conduct industry experts’ interviews, TechSci formulated a detailed discussion guide.
Developing List of Respondents
Data Collection
Data Validation
Data obtained as a result of primary and secondary research was validated through rigorous triangulation.
TechSci conducted interviews with industry experts and industry players for data collection and verification.
List of industry players and industry specialists was developed.
Primary Research
Data Collection
Data Filter & Analysis
Research & Intelligence
Actionable Insights
Desk Research
✓ Identifying Key Opinion Leaders
Business Solution
✓ Questionnaire Design
✓ ✓
LinkedIn TechSci Internal Database
✓ ✓ ✓ ✓ ✓
Company Websites Company Annual Reports White Paper Study Financial Reports Investor Presentations Regulatory Body Associations, etc.
Company Analysis
✓ Recent Developments
✓ Market Participants
✓ Market Changing Aspects/Dynamics
✓ Key Strengths
✓ Conclusion
Secondary Research ✓ ✓
The data was scrutinized using MS-Excel, statistical tools and internal proprietary database to obtain qualitative and quantitative insights about the global glycobiology market.
✓ Government Policies
✓ In-depth Interviews
Primary Research
Data Analysis
Paid Sources
✓ ✓
Factiva Hoovers
18
Research Methodology Baseline Methodology
Our dedicated team of industry experts has monitored and analyzed various aspects of the global glycobiology market. The team has analyzed the outlook of various segments of this market, while considering the major influencing factors such as growing prevalence of chronic diseases such as cancer, diabetics, renal diseases, etc. and increased drug discovery process around the globe, among others. The study includes market forecasting, which would enable our clients to take better decisions while planning their strategy to achieve sustainability in the global glycobiology market.
Methodology Followed for Calculation of Market Size:
• Market Size by Value: Market size, in terms of value, for the year 2019 was calculated based on information collected through exhaustive secondary research and primary surveys, with various key opinion leaders/stakeholders, such as companies, suppliers, distributors, market influencers & End User, industry experts, and other industry participants.
• The team interviewed more than 15 – 20 companies, 100 – 120 End User, 15 – 20 industry experts and other value chain stakeholders in the global glycobiology market to obtain the overall market size from 2015 to 2019, which was validated by the Delphi technique. Taking standard deviation into consideration, the market size was averaged out, to arrive at the market size data during 2015-2019.
19
Research Methodology • Respondents were asked about the current and future market growth rates, market shares by type of enzyme, by type of kit, by application, by end user, by each region, and by company. Removing the outlier responses, the geometric mean of growth estimates and provider wise revenue shares
generated across various segments were considered, to arrive at the final revenue shares. Revenue shares generated across various segments were further triangulated from other stakeholders.
Methodology Followed for Calculation of Market Shares: • Market shares shares by type of enzyme, by type of kit, by application, by end user, by each region, and by company were calculated based on the
responses received through primary surveys with industry experts, in which the respondents were asked about the market shares or revenue generated from various segments of glycobiology market. The final shares were calculated by taking the geometric mean of the responses gathered from key opinion leaders after eliminating the outliers. Methodology Followed for Forecasting: • TechSci Research performed periodical checks on data collected through the surveys with logic checks and analyzed the survey results in SPSS/Tableau Software. • Data triangulation techniques were applied to fill the gaps and to present a more meaningful picture of the market. To forecast global glycobiology market, TechSci Research used various forecast techniques such as: ✓
Moving Average
✓
Time Series Analysis
✓
Regression Analysis
✓
Econometric and Judgmental Analysis
20
Research Methodology TechSci Research used its own forecast tool, which is based on the growth of various allied industries in respective regions. TechSci Research also used the impact analysis during short, medium and long term period to estimate the demand and to reach accurate market numbers. It should be noted that the figures compiled are only for the organized market including market share data. The currency used in the report is the United States Dollar (USD),
with the market size indicated in USD million.
Partial List of Companies Interviewed
Key Secondary Sources
▪
Merck & Co., Inc.
▪
World Bank
▪
Agilent Technologies, Inc.
▪
TechSci Research Proprietary Database & Knowledge Repository
▪
Thermo Fisher Scientific
▪
Company Annual Reports
▪
New England Biolabs, Inc.
▪
Industry Magazines
▪
Shimadzu Corporation
▪
Industry Reports
▪
Takara Bio Inc.
▪
News Dailies
▪
Waters Corporation
▪
Credible Paid Databases
▪
Asparia Glycomics S.L.
▪
Bruker Corporation
▪
RayBiotech, Inc.
▪
Z Biotech, LLC.
▪
Chemily Glycoscience
▪
Dextra Laboratories Ltd.
▪
Lectenz Bio
▪
Ludger Ltd
▪
R&D Systems, Inc.
▪
Bio-Techne
▪
Danaher Corporation
▪
S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan)
▪
ProZyme
21
Industry Brief According to TechSci Research report, “Global Glycobiology Market By Type of Enzyme (Glycosidases & Neuramidases, Glycosyltransferases & Sialytransferases, Carbohydrate kinases, Carbohydrate Sulfotransferases, Protein Sulfotransferases, Others),
By Type of Kit (Glycan Releasing Kit, Glycan Labelling Kit, Glycan Purification Kit, Others), By Application (Drug Discovery,
Disease Diagnostics, Virology, Cell Biology, Oncology, Others), By End User (Research Institutes, Diagnostic Centers, Hospitals, Clinical Laboratories, Pharmaceutical & biotechnology companies, Others), By Region, Forecast & Opportunities, 2025�, the global glycobiology market is expected to grow at a formidable rate during the forecast period on account of the increasing R&D activities
related to glycomics and proteomics. Additionally, ongoing technological advancements especially in the instrumentations and kits used in glycobiology technique coupled with the novel product launches by the major players operating in the market is further expected to propel the market during forecast period. Also, the use of glycobiology in the anti-cancer drug discovery is anticipated to spur the growth of market over the next few years. Furthermore, the use of glycomics in the field of dermatology for studying the aging pattern of the skin is expected to positively impact the growth of
market through 2025. Also, synthesis, differentiation and proliferation of skin can be achieved using glycobiology thereby increasing its application in tissue architecture. However, high costs of the instrumentation, tools or kits used in the technique make it expensive which can hamper the growth of market during forecast period. Additionally, stringent government policies also hinder the market growth. Moreover, the technique requires skilled personnel to perform it and lack of such skilled people might impede the growth of market over the next few years.
The global glycobiology market is segmented based on type of enzyme, type of kit, application, end user, company and region. Based on the type of kit, the market can be categorized into glycan releasing kit, glycan labelling kit, glycan purification kit and others. The glycan releasing kit segment is expected to dominate the market since these kits are applicable for different enzymes such as glycosyltransferases, sialyltransferases, sulfotransferases, among others that generate leaving groups with a removable phosphate. Additionally, these kits are quantitative, convenient and amenable to high throughput analysis. Based on application, the market can be fragmented into drug discovery, disease diagnostics, virology, cell biology, oncology and others. The drug discovery segment is
expected to dominate the market on account of the increasing demand for personalized medicines. Additionally, increasing R&D activities by the major players operating in the market and different governments around the globe for the development of novel therapeutics is further anticipated to drive the growth of this segment during the next five years. Based on end user, the market can be grouped into research institutes, diagnostic centers, hospitals, clinical laboratories, pharmaceutical & biotechnology companies and others. The pharmaceutical & biotechnology companies segment is expected to register highest CAGR during the forecast period. This can be accredited to the growing demand for new drug discovery and development especially for treatment of chronic diseases such as diabetes, cancer, among others.
Merck & Co., Inc., Agilent Technologies, Inc., Thermo Fisher Scientific, New England Biolabs, Inc., Shimadzu Corporation, Takara Bio Inc., Waters Corporation, Asparia Glycomics S.L., Bruker Corporation, RayBiotech, Inc., Z Biotech, LLC., Chemily Glycoscience, Dextra Laboratories Ltd., Lectenz Bio, Ludger Ltd, R&D Systems, Inc., Bio-Techne, Danaher Corporation, S-BIO (subsidiary of
Sumitomo Bakelite Co. Ltd., Japan), ProZyme and others are some of the leading players operating in global glycobiology market. The companies operating in the market are using organic strategies such as product launches, mergers and collaborations to boost their share. For instance, in June 2019, Agilent Technologies (US) launched InfinityLab LC/MSD iQ System.
22
Sample Data - Snapshot Global Glycobiology Market Size, By Value (USD Million), 2015-2025F
5.00
2015
8.00
7.00
6.00
CAGR By Value
XX%
9.00
10.00
2019
2020E
11.00
14.00
13.00
12.00
CAGR By Value
2025F
YY%
By Value (USD Million)
15.00
North America Glycobiology Market Share, By Type of Enzyme, By Value, 2015–2025F Glycosidases & Neuramidases Carbohydrate Kinases Protein Sulfotransferases 2025F 2024F 2023F 2022F 2021F 2020E 2019 2018 2017 2016 2015
20% 20% 20% 20% 20% 20% 20% 20% 20% 20% 20%
20% 20% 20% 20% 20% 20% 20% 20% 20% 20% 20%
20% 20% 20% 20% 20% 20% 20% 20% 20% 20% 20%
Glycosyltransferases & Sialytransferases Carbohydrate Sulfotransferases Others
20% 20% 20% 20% 20% 20% 20% 20% 20% 20% 20%
United States Glycobiology Market Share, By Type of Kit, By Value, 2015–2025F
Glycan Releasing Kit 2025F 2024F 2023F 2022F 2021F 2020E 2019 2018 2017 2016 2015
25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25%
Glycan Labelling Kit
25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25%
Glycan Purification Kit
25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25%
10% 10% 10% 10% 10% 10% 10% 10% 10% 10% 10%
10% 10% 10% 10% 10% 10% 10% 10% 10% 10% 10%
Others
25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25%
23
Report Ordering
Report Name: GLOBAL GLYCOBIOLOGY MARKET
FORECAST & OPPORTUNITIES 2015 – 2025 License Type
Price
Single User License
$4450
Multi-User License
$5450
Custom Research License
$9450
To View Sample OR Purchase Report
24
About Us & Disclaimer
TechSci Research is a global market research and consulting company with offices in the US, UK and India. TechSci Research provides market research reports in number of areas to organizations. The company uses innovative business models that focus on improving productivity, while ensuring creation of high-quality reports. The proprietary forecasting models use various analyses of both industry-specific and macroeconomic variables on a state-by-state basis to produce a unique ‘bottom-up’ model of a country, regional and
global industry prospects. Combined with the detailed analysis of company activity and industry trends, the result is a uniquely rich evaluation of the opportunities available in the market.
Related Reports •
Global Portable Ventilator Market, By Application (Invasive Ventilation, Non-Invasive Ventilation), By Mode (Pressure Mode Ventilation; Volume Mode Ventilation; Combined Mode Ventilation), By Application (Aeromedical; Pediatrics; Domiciliary Ventilation; Non-Invasive Ventilation), By End User (Hospital; Ambulance; Clinic; Rehabilitation Center; Others), By Region, Forecast & Opportunities, 2025
•
Global Biomedical Refrigerators and Freezers Market, By Product (Pass-Through, Explosion Safe, Flammable storage, Combo/Dual Temperature, Others), By Storage (Blood, Vaccines, Plasma, DNA, Flammable chemicals, Others), By Temperature (RNA & DNA, Vaccines), By Capacity (138L, 169L, 221L, 230L, 426L, 690L, Others), By End-user (Hospitals, Pharmacies, Diagnostic Centers, Research Laboratories, Blood Banks), By Region, Forecast & Opportunities, 2025 TechSci Research – North America 708 Third Avenue, Manhattan, New York, United States Tel: +1- 646- 360- 1656 Email: sales@techsciresearch.com www.techsciresearch.com
TechSci Research – Europe
54, Old brook, Bretton, Peterborough, United Kingdom Email: sales@techsciresearch.com www.techsciresearch.com
TechSci Research – Asia-Pacific
B – 44, Sector – 57, Noida, National Capital Region, U.P. - India Tel: +91-120-4523900 Email: sales@techsciresearch.com www.techsciresearch.com
Disclaimer The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely, accurate or complete. TechSci Research has taken due care and caution in compilation of data as this has been obtained from various sources including which it considers reliable and firsthand. However, TechSci Research does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible for any errors or omissions or for the results obtained from the use of such information and especially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together with all estimates and forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require prior approval of TechSci Research.